Advertisement

Topics

Approval for first drug against rare type of cancer in Japan

07:51 EDT 3 Jul 2017 | thePharmaLetter

Teijin Pharma and French firm Ipsen have received approval from Japan’s medicines regulator to market…

Original Article: Approval for first drug against rare type of cancer in Japan

NEXT ARTICLE

More From BioPortfolio on "Approval for first drug against rare type of cancer in Japan"

Advertisement
Quick Search
Advertisement
Advertisement